Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE4A | P27815 | 1/20 | 0.52 |
| ▸ | LMNA | P02545 | 2/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.50 |
| ▸ | USP2 | O75604 | 1/20 | 0.48 |
| ▸ | SLCO1B1 | Q9Y6L6 | 1/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.48 |
| ▸ | PGD | P52209 | 1/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.36 |
| ▸ | TGFBR1 | P36897 | 1/20 | 0.32 |
| ▸ | OR51E2 | Q9H255 | 1/20 | 0.32 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL122819 | 1.00 | PDE4A (0.52) | PDE4ALMNAL3MBTL1USP2SLCO1B1 | |
| SCHEMBL4638447 | 1.00 | PDE4A (0.52) | PDE4ALMNAL3MBTL1USP2SLCO1B1 | |
| SCHEMBL2126263 | 1.00 | PDE4A (0.52) | PDE4ALMNAL3MBTL1USP2SLCO1B1 | |
| SCHEMBL7151302 | 1.00 | PDE4A (0.52) | PDE4ALMNAL3MBTL1USP2SLCO1B1 | |
| SCHEMBL1591176 | 1.00 | PDE4A (0.52) | PDE4ALMNAL3MBTL1USP2SLCO1B1 | |
| SCHEMBL6665411 | 1.00 | PDE4A (0.52) | PDE4ALMNAL3MBTL1USP2SLCO1B1 | |
| SCHEMBL1569332 | 0.92 | PDE4A (0.62) | PDE4ALMNAL3MBTL1USP2SLCO1B1 | |
| SCHEMBL5268306 | 0.92 | PDE4A (0.62) | PDE4ALMNAL3MBTL1USP2SLCO1B1 | |
| SCHEMBL2912046 | 0.92 | PDE4A (0.62) | PDE4ALMNAL3MBTL1USP2SLCO1B1 | |
| SCHEMBL20576207 | 0.92 | PDE4A (0.62) | PDE4ALMNAL3MBTL1USP2SLCO1B1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112851730-B | Synthesis method of NMN intermediate NR chloride | 厦门瑞林药业有限公司 | 2023-02-21 | — | — | CN | disclosed |
| EP-3625225-B1 | LDHA ACTIVITY INHIBITORS | ARCTIC PHARMA AS (NO) | 2022-06-29 | — | — | EP | disclosed |
| CN-112851730-A | Synthesis method of NMN intermediate NR chloride | 厦门瑞林药业有限公司 | 2021-05-28 | — | — | CN | disclosed |
| CN-106659765-A | Use of dianhydrogalactitol and analogs or derivatives thereof to treat non-small-cell carcinoma of the lung and ovarian cancer | 德玛医药 | 2017-05-10 | — | — | CN | disclosed |
| CN-101801997-B | Vaccines against bordetella pertussis based on the improvement of LPS glycosyl transferase mutant | DE STAAT DER NEDERLANDEN, VERT. DOOR DE MINISTER VAN VWS (NL) | 2016-06-01 | — | — | CN | disclosed |
| WO-2008034575-A1 | IMINOSUGAR GLYCOCONJUGATES | TECHNISCHE UNIVERSITÄT GRAZ (AT) | 2008-03-27 | — | — | WO | disclosed |